Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Healthcare
Karyopharm Therapeutics Inc. annual/quarterly shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Karyopharm Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were -292.9M, a 57.47% increase year-over-year.
- Karyopharm Therapeutics Inc. shareholder equity for 2025 were -292.9M, a 57.47% increase from 2024.
- Karyopharm Therapeutics Inc. shareholder equity for 2024 were -186.0M, a 36.57% increase from 2023.
- Karyopharm Therapeutics Inc. shareholder equity for 2023 were -136.2M, a 717.76% increase from 2022.
- Karyopharm Therapeutics Inc. shareholder equity for 2022 were -16.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Karyopharm Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-293 |
| 2024 | $-186 |
| 2023 | $-136 |
| 2022 | $-17 |
| 2021 | $-80 |
| 2020 | $51 |
| 2019 | $50 |
| 2018 | $183 |
| 2017 | $129 |
| 2016 | $162 |
| 2015 | $198 |
| 2014 | $207 |
| 2013 | $155 |
| 2012 | $-28 |
| Karyopharm Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $-293 |
| 2024-12-31 | $-186 |
| 2023-12-31 | $-136 |
| 2022-12-31 | $-17 |
| 2021-12-31 | $-80 |
| 2020-12-31 | $51 |
| 2019-12-31 | $50 |
| 2018-12-31 | $183 |
| 2017-12-31 | $129 |
| 2016-12-31 | $162 |
| 2015-12-31 | $198 |
| 2014-12-31 | $207 |
| 2013-12-31 | $155 |
| 2012-12-31 | $-28 |
Karyopharm Therapeutics Inc. Shareholder Equity — FAQ
Karyopharm Therapeutics Inc. (KPTI) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPTI's shareholder equity history?
The chart and table above show Karyopharm Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.